Alzheimer's Disease (AD)

About Alzheimer's Disease (AD)

Alzheimer’s Disease is a progressive neurodegenerative brain disorder that gradually destroys memory, cognitive function, and the ability to carry out simple daily tasks, ultimately leading to severe functional dependence and brain failure.

As the leading cause of dementia (accounting for 60% to 80% of cases), Alzheimer’s develops insidiously—often beginning decades before outward clinical symptoms emerge—and impairs functioning across four primary domains:

Cognitive & Memory Deficits: Profound short-term memory loss (difficulty retaining new information), disorientation to time and place, impaired judgment, and language difficulties (e.g., word-finding trouble, loss of fluency).

Executive Functioning Decline: Progressive difficulty with multi-step planning, complex problem-solving, managing finances, and organizing familiar daily routines.

Behavioral & Neuropsychiatric Shifts: Personality shifts, apathy, anxiety, depression, agitation, sleep-wake cycle disruptions, and, in moderate-to-advanced stages, delusions, paranoia, or hallucinations.

Motor & Physical Loss: In advanced stages, gradual loss of motor control leading to difficulty walking, swallowing, maintaining balance, and managing basic physiological self-care.

Because Alzheimer's-related brain changes begin decades before cognitive symptoms manifest, early and continuous screening is vital. Proactive testing offers a critical window to help prevent or even reverse early-stage symptoms—a step that is especially urgent for individuals carrying high-risk genetic variants.

Frequency: An estimated 7.4 million Americans and 55 million people worldwide are currently living with the disease. Driven by an aging baby-boomer population alongside modern lifestyle and environmental factors, this U.S. figure alone is projected to climb to nearly 13.8 million by 2060, barring major medical breakthroughs.

Age Distribution: The risk of developing Alzheimer’s escalates sharply with age. It affects roughly 5.2% of people ages 65 to 74, 13.8% of those ages 75 to 84, and 35.8% of adults age 85 and older.

Younger-Onset: While it primarily impacts seniors, about 200,000 Americans under the age of 65 live with younger-onset Alzheimer's.

Gender Differences: Gender represents a significant dividing line; almost two-thirds of Americans living with the disease are women.

Race & Ethnicity: Older Black Americans are roughly twice as likely to have Alzheimer's or other dementias compared to older White Americans. Older Hispanic Americans are about 1.5 times as likely to develop the disease.

Types and classifications

• Alzheimer's disease is traditionally classified into two primary categories based on the age of onset. Early-onset and late-onset. While it has long been considered a condition of old age, growing research suggests that pathological changes can begin much earlier in life, with initial signs appearing in people as young as their 20s or 30s. In addition to these two types, the people with the disease are often categorized by the stage of disease.
• Late-Onset Alzheimer's: The most common form, developing in individuals aged 65 and older. It arises from a complex mix of genetics, lifestyle factors, and environmental influences rather than a single direct cause.
• Early-Onset Alzheimer's: This rarer form of the disease appears before age 65, often in a person's 40s or 50s. It tends to have a stronger genetic link, such as variants like the APOE4 allele, though these genes indicate increased risk rather than a guaranteed outcome. Lifestyle and environmental factors also play significant roles in whether the disease develops.
• Alzheimer's Disease Stages
• Mild / Early-Stage (2 to 4 years): The individual can generally function independently but begins experiencing noticeable memory lapses and cognitive decline, such as forgetting recent events, misplacing items, struggling for words, and having trouble organizing tasks.
• Moderate / Middle-Stage (2 to 10 years): Typically the longest phase, requiring increased supervision as brain cell damage causes deeper memory gaps, greater confusion (wandering or getting lost), personality and sleep changes, and difficulty with daily tasks like dressing or bathing.
• Severe / Late-Stage (1 to 5 years): Cognitive and physical functions decline significantly, leading to a loss of speech, mobility, bodily control, and memory. Individuals in this final stage require 24/7 around-the-clock care.
• Late/Severe Stage: In the late (severe) stage, individuals lose the ability to communicate effectively, recognize loved ones, or care for themselves, requiring full-time assistance with basic activities like eating and walking; motor function declines significantly, and complications such as infections or swallowing problems become common.
• Functional medicine practitioners and functional neurologists define Alzheimer’s disease as a network of metabolic and systemic insults rather than a single uniform condition. They primarily utilize frameworks like the Bredesen Protocol pioneered by Dr. Dale Bredesen, categorizing cognitive decline into distinct functional subtypes based on underlying root-cause drivers.
• Type 1 (Inflammatory / "Hot"): Driven by chronic systemic or neuroinflammation originating from sources like poor diet, gut dysbiosis, or persistent infections, which upregulates amyloid-producing molecules.
• Type 1.5 (Glycotoxic): Characterized by insulin resistance and chronically high blood sugar, leading to glucose dysregulation, cellular energy starvation, and a secondary pro-inflammatory state.
• Type 2 (Atrophic / "Cold"): Resulting from a deficiency or withdrawal of vital trophic supports, such as essential nutrients (Vitamin D, B12) and hormones (thyroid, estradiol, testosterone) required to maintain neural plasticity.
• Type 3 (Toxic / "Vile"): Stemming directly from exposure to environmental or biological toxins, such as heavy metals (mercury) or biotoxins (mold/mycotoxins), often presenting earlier in life with non-amnestic cortical symptoms like aphasia.
• Type 4 (Vascular): Triggered by cardiovascular and cerebrovascular compromise that restricts oxygen and glucose delivery to brain tissue.
• Type 5 (Traumatic): Linked to a history of significant physical head trauma or concussions.

Symptoms associated in the NPA database

The NPA Treatment Database groups the following symptom information with Alzheimer's Disease (AD). This list is educational and is not a diagnostic checklist.

Treatment information in the database

The NPA Treatment Database lists 16 treatment records in connection with Alzheimer's Disease (AD). A database relationship does not establish that a treatment is effective, safe, or appropriate for any individual.

• Apollo Health / Dr. Dale Bredesen Protocol
• BrainHQ
• Cognitive Stimulation Therapy (CST)
• Dance & Movement Therapy
• Designs for Strong Minds
• Dr. Heather Sandison / Reversing Alzheimer's Protocol
• Equipping Minds
• Hyperbaric Oxygen Therapy (HBOT)
• KAATSU / Blood Flow Restriction Training
• LearningRx
• LiveO2 (Adaptive Contrast Oxygen Training)
• Music and Art Therapy
• Photobiomodulation (PBM) / Professionally Delivered Red/Near-Infrared Light Therapy
• Plasticity Brain Center
• Task-Specific Training
• The Wahls Protocol

Related questions

These controlled question pages use the same stored condition and treatment relationships.

• What treatments are listed for Alzheimer's Disease (AD) in the NPA database?

Recommended reading listed by NPA

These titles come from the current NPA condition record. Structured citation details are not yet available.

• Learning to Speak Alzheimer's: The New Approach to Living Positively with Alzheimer's Disease by Joanne Koenig Coste — Offers a positive, connection-focused approach to communicating with and caring for people living with Alzheimer's.
• Outlive: The Science and Art of Longevity by Peter Attia, M.D. — A comprehensive framework for extending healthspan that includes strategies to protect the brain from neurodegenerative disease.
• Reversing Alzheimer's: The New Toolkit to Improve Cognition and Protect Brain Health by Heather Sandison with Kate Hanley — A practical toolkit combining lifestyle, nutrition, and targeted interventions to improve cognition and protect the brain.
• Soft-Wired: How the New Science of Brain Plasticity Can Change Your Life by Michael Merzenich, PhD — From a pioneering neuroscientist, practical principles for driving positive brain change at any age through targeted practice and experience.
• The Brain That Changes Itself: Stories of Personal Triumph from the Frontiers of Brain Science by Norman Doidge — Landmark exploration of neuroplasticity featuring dramatic recoveries from stroke, brain injury, and other neurological challenges.
• The Brain's Way of Healing: Remarkable Discoveries and Recoveries from the Frontiers of Neuroplasticity by Norman Doidge — Shows how light, sound, vibration, and movement can awaken the brain's self-healing capacities after injury and illness.
• The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline (ReCODE Protocol) by Dale E. Bredesen, M.D. — Introduces the multi-factorial ReCODE protocol that targets underlying drivers of cognitive decline rather than a single pathology.